SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-161600
Filing Date
2023-06-06
Accepted
2023-06-06 16:05:55
Documents
13
Period of Report
2023-05-31
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d390817d8k.htm   iXBRL 8-K 27734
2 EX-10.1 d390817dex101.htm EX-10.1 5657
  Complete submission text file 0001193125-23-161600.txt   161882

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA freq-20230531.xsd EX-101.SCH 2849
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE freq-20230531_lab.xml EX-101.LAB 18736
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE freq-20230531_pre.xml EX-101.PRE 11706
7 EXTRACTED XBRL INSTANCE DOCUMENT d390817d8k_htm.xml XML 3472
Mailing Address 75 HAYDEN AVENUE SUITE 300 LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE SUITE 300 LEXINGTON MA 02421 781-315-4600
Frequency Therapeutics, Inc. (Filer) CIK: 0001703647 (see all company filings)

IRS No.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39062 | Film No.: 23996115
SIC: 2834 Pharmaceutical Preparations